Table 1.
Database | Private (CCAE) |
Medicaid (MDCD) |
Medicare (MDCR) |
|||
---|---|---|---|---|---|---|
Retained | Excluded | Retained | Excluded | Retained | Excluded | |
Met age requirement1 | 25,791,353 | 1,905,877 | 3,042,893 | |||
Not in database for ≥1 year | 9,529,651 | 577,802 | 815,715 | |||
Exclusion diagnosis in past year | 198,072 | 146,951 | 161,739 | |||
Dispensed an AD in past year | 1,942,436 | 175,260 | 321,987 | |||
Study cohort2 | 14,121,194 | 1,005,864 | 1,742,452 | |||
No AD dispensed in 2011 | 13,572,434 | 957,464 | 1,664,954 | |||
AD dispensed in 2011 but no accompanying depression diagnosis3 | 378,271 | 27,586 | 64,097 | |||
Incident PTD cases | 170,489 | 20,814 | 13401 |
Age in 2011 was 14–60 years (inclusive) for CCAE and MDCD, or at least 65 years for MDCR.
The population from which the pharmaceutically treated depression patients were identified, i.e., the base population from which incidence rates were calculated.
To be considered an accompanying depression diagnosis, the diagnosis needed to be between 30 day before and 180 days after the AD dispensing.